1. Home
  2. YEXT vs DCTH Comparison

YEXT vs DCTH Comparison

Compare YEXT & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$7.39

Market Cap

644.4M

Sector

Technology

ML Signal

HOLD

DCTH

Delcath Systems Inc.

HOLD

Current Price

$14.50

Market Cap

578.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
DCTH
Founded
2006
1988
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.4M
578.4M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
YEXT
DCTH
Price
$7.39
$14.50
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $24.00
AVG Volume (30 Days)
★ 655.9K
253.4K
Earning Date
12-07-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 131.82
107.53
EPS
★ 0.15
0.04
Revenue
★ $170,201,000.00
N/A
Revenue This Year
N/A
$24.61
Revenue Next Year
$1.04
$24.27
P/E Ratio
★ $48.87
$360.50
Revenue Growth
N/A
N/A
52 Week Low
$3.27
$8.12
52 Week High
$9.03
$17.42

Technical Indicators

Market Signals
Indicator
YEXT
DCTH
Relative Strength Index (RSI) 69.53 41.02
Support Level $6.04 $14.00
Resistance Level $7.91 $16.51
Average True Range (ATR) 0.22 0.49
MACD 0.04 -0.05
Stochastic Oscillator 97.89 26.92

Price Performance

Historical Comparison
YEXT
DCTH

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: